Wednesday, November 16, 2011

Celsion Opportunity

Sell The Call came across Celsion. It is a drug maker focused on oncology drugs. The market cap is only $80 million. But the December call values are extremely high. For example, the Dec $3.50 call was going for $0.35. With the stock around $3.10, there is both income from the call and possible appreciation value with the stock itself.

If you are willing to take the risk, or already own shares in this company and are looking to hedge, making a covered call trade on this stock is an option.

- Don't forget to visit the web page for Sell The Call, like our Sell The Call Facebook Page and follow our Sell The Call Twitter page! 

- This information is not to be used as a recommendation to buy or sell. It is simply information and opinions. Before investing, please consult a financial professional. Sell The Call takes no responsibility for any losses or gains that occur from trades using its material.

- The account does not fully divulge all information (the size of shares bought and calls sold) on open trades. This is for protection of the trade. When the trade on a particular stock ends, the account will give the size information out. Please feel free to ask questions and Sell The Call will answer them the best way possible can without endangering the trade. THE ACCOUNT WILL NOT MISLEAD READERS TO CREATE A GAIN ON ITS TRADES!
- If you have any info regarding call selling, be sure to comment or send an email. The goal of the blog is to collaborate so that we all can accumulate wealth with the help of selling calls. Please pass the blog address to others that might find some value from it.

No comments:

Post a Comment